Technical Analysis for RTTR - Ritter Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade F 0.68 -1.45% -0.01
RTTR closed down 1.45 percent on Friday, January 18, 2019, on 1.33 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical RTTR trend table...

Date Alert Name Type % Chg
Jan 18 20 DMA Resistance Bearish 0.00%
Jan 18 NR7 Range Contraction 0.00%
Jan 18 Wide Bands Range Expansion 0.00%
Jan 18 Down 3 Days in a Row Weakness 0.00%
Jan 18 Down 4 Days in a Row Weakness 0.00%
Jan 17 Fell Below 20 DMA Bearish -1.45%
Jan 17 Inside Day Range Contraction -1.45%
Jan 17 Wide Bands Range Expansion -1.45%
Jan 17 Down 3 Days in a Row Weakness -1.45%
Jan 16 20 DMA Support Bullish -6.85%

Older signals for RTTR ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Ritter Pharmaceuticals, Inc. develops novel therapeutic products, which modulate the human gut microbiome to treat inflammatory, gastrointestinal, and metabolic diseases. Its lead product candidate is RP-G28, a novel microbiome modulator, which is under development for the reduction of symptoms associated with lactose intolerance. RP-G28 is designed to stimulate the growth of lactose-metabolizing bacteria in the colon, thereby adapting the gut microbiome to assist in digesting the lactose that reaches the large intestine. RP-G28 has been studied in a Phase 2a clinical trial. The company was formerly known as Ritter Natural Sciences, LLC and changed its name to Ritter Pharmaceuticals, Inc. in September 2008. Ritter Pharmaceuticals, Inc. was founded in 2004 and is headquartered in Los Angeles, California.
Is RTTR a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 4.0
52 Week Low 0.47
Average Volume 104,893
200-Day Moving Average 1.9754
50-Day Moving Average 0.7898
20-Day Moving Average 0.7118
10-Day Moving Average 0.7784
Average True Range 0.1088
ADX 21.84
+DI 16.6765
-DI 16.7947
Chandelier Exit (Long, 3 ATRs ) 0.6236
Chandelier Exit (Short, 3 ATRs ) 0.7964
Upper Bollinger Band 0.9437
Lower Bollinger Band 0.4799
Percent B (%b) 0.43
BandWidth 65.158753
MACD Line -0.0197
MACD Signal Line -0.0235
MACD Histogram 0.0037
Fundamentals Value
Market Cap 10.04 Million
Num Shares 14.8 Million
EPS -1.33
Price-to-Earnings (P/E) Ratio -0.51
Price-to-Sales 0.00
Price-to-Book 1.81
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.77
Resistance 3 (R3) 0.78 0.75 0.76
Resistance 2 (R2) 0.75 0.73 0.75 0.75
Resistance 1 (R1) 0.72 0.72 0.71 0.71 0.74
Pivot Point 0.69 0.69 0.69 0.69 0.69
Support 1 (S1) 0.66 0.67 0.65 0.65 0.62
Support 2 (S2) 0.63 0.66 0.63 0.61
Support 3 (S3) 0.60 0.63 0.61
Support 4 (S4) 0.59